Medical Devices & Technology Archive

Continuous positive airway pressure (CPAP) is a first-line treatment for people with obstructive sleep apnea. The CPAP keeps the airway open by pushing a forceful stream of air through a tube and into a mask worn during sleep. The air comes from a small bedside pump (an air compressor). Other forms of positive airway pressure (PAP) may be helpful for people with central sleep apnea. Doctors determine which type of PAP therapy and device someone needs. Patients select the type of PAP mask to use with the system.

Some medical alert systems now have advanced technology that integrates monitoring services with a smartphone, smart watch, or smart speaker. The services aren't cheap. They range from $20 to $50 per month, depending on the company and any additional services (such as fall detection). There may also be fees for activation and equipment (up to a few hundred dollars). The alternative is getting an alert system that isn't monitored, such as free "panic button" apps for smartphones or a smart watch that can notify relatives in an emergency.

Many home blood pressure monitors are not validated for accuracy, which means there's no way to know if information they provide is correct. Relying on inaccurate measurements can affect decisions people make about medical treatment. Fortunately, reliable organizations have developed lists of blood pressure monitors that have demonstrated clinical accuracy. If a blood pressure monitor isn't listed, it's probably not validated.

Five smart watches capable of recording an electrocardiogram and detecting atrial fibrillation have been cleared for the market by the FDA. The devices can continuously monitor a person's pulse for an abnormally rapid heart rate and tell the wearer when to record an ECG, which involves opening an app and touching the side of the watch for 30 seconds. But it's not clear if using this feature can improve a person's health. There are many other ways to screen for afib. These strategies, which include simply checking one's pulse or wearing a heart monitor, depend on a person's afib risk and symptoms.

For people who buy over-the-counter hearing aids, getting the devices is only a first step toward better hearing. It takes time to learn how to use, wear, and adjust the hearing aids, especially during the first two weeks. Tips to ease through this adjustment period include wearing devices at home for at least a few hours per day, and longer if possible; allowing soft sounds to be louder than normal at first; and learning to switch device settings for changes in environmental noise, such as going from a quiet street into a noisy restaurant.

A 2023 study suggests that the type of technology used in smart watches to measure the heart's electrical activity may have the potential to detect early signs of heart failure or atrial fibrillation.

ECG readings taken with a smart watch may be just as accurate as a traditional ECG done in a medical setting. But the notion of using a smart watch to diagnose a heart attack is still years away. One main reason: obtaining an ECG with a smart watch requires carefully holding the back of the watch on the wrist and at eight specific locations on the chest and abdomen. Quality control and regulatory issues are other important hurdles that need to be addressed. But experts believe improved smart watches with enhanced diagnostic ability may be on the market within a decade.

Maximum heart rate refers to the upper limit of what a person's cardiovascular system can handle during exercise. It can be estimated by subtracting the person's age from 220. Target heart rates (which range from 64% to 93% of the maximum) can help people know if they are doing moderate or vigorous exercise. Physical activity guidelines recommend that people get at least 150 minutes of moderate-intensity exercise or 75 minutes of vigorous-intensity exercise, or a combination of both, per week.

The Watchman, a tiny, basket-like device placed in the heart's left atrial appendage, is designed to prevent blood clots traveling from the heart to the brain and causing stroke. People with atrial fibrillation who face a high risk of bleeding from anti-clotting drugs may be good candidates for the device.

A gene editing technique that permanently shuts down a cholesterol-raising protein called PCSK9 is being tested in heart attack survivors with an inherited form of high cholesterol. The one-time infusion contains tiny particles that contain the editing tools, which travel through the blood to the liver and changes the cells that produce the protein. If early data show the treatment to be safe and effective, the therapy potentially could be used in people who have "garden variety" high cholesterol.